Skip to content
Daily Circle provides in-depth news, cultural stories, and …

Giving Pluripotent Cells in Utero to Babies with Neural Tube Defect Enhances Quality of Life, Trial Finds

An innovative medical trial has found that administering stem cells to developing infants affected by spina bifida as part of a surgical repair may represent a "significant breakthrough" in addressing congenital conditions.

Study Parameters and Security

The US-based trial involved six unborn babies with the 'open' form of spina bifida. Doctors administered mother's placental stem cells directly onto the infant's spine while the defect was being closed.

Critically, the regenerative treatment proved to be secure. Doctors verified that the treatment did not lead to cancerous growths, disrupt the healing process, or prevent the reversal of co-occurring hindbrain herniation.

Promising Outcomes

Post-birth MRI scans indicated a complete reversal of Chiari malformation in each of the babies. This favorable anatomical change is closely linked to better mobility and function.

"If it makes a greater number of infants capable of walking who previously could not, it may emerge as the new treatment paradigm," said the lead researcher. "These findings are profoundly encouraging and create a pathway toward lots of potential novel therapies."

Future Implications and Hope

Commentators reviewing the findings proposed that subsequent studies of these noted improvements could announce a "fresh chapter" in prenatal intervention. The possibility of ameliorating neurological damage occurring during fetal development is considered a revolutionary objective.

Notably important would be advancements for continence and digestive health, which are common challenges for individuals living with this defect.

Looking Ahead

Although this preliminary study was small in scale, its safety demonstration and positive signals offer a robust platform for larger, more comprehensive studies. The integration of stem cell therapy with current in-utero repair procedures holds considerable promise for transforming outcomes for future generations with myelomeningocele.

About the author

April Pitts

Maya Chen is a journalist and cultural commentator based in Toronto, focusing on Canadian social issues and community stories.

Daily Circle

Type to search articles.